openPR Logo
Press release

Improved microbiome sequencing capabilities are likely to boost the global microbiome therapeutics market

Improved microbiome sequencing capabilities are likely

According to the latest market report published by Persistence Market Research, titled ‘Microbiome Therapeutics Market Potential: Global Pipeline Analysis and Assessment 2018 – 2025’, the global microbiome therapeutics market is expected to exhibit an exponential CAGR of 62.9% during the forecast period 2018–2025.

Request for sample report:

Persistence Market Research estimates that the global market for microbiome therapeutics is expected to be valued at US$ 10.1 Mn in 2018 and is expected to reach US$ 897.3 Mn by 2025 end. Need for reliable, precise and fast treatment options for certain diseases, such as C. difficile infection (CDI), phenylketonuria, hepatic encephalopathy and multidrug resistant urinary tract infection creates a huge potential for the growth of the microbiome therapeutics market. Breakthrough therapy designation and orphan drug approvals for microbiome therapeutics is expected to accelerate the launch of developmental drugs in the microbiome therapeutics market. A huge pipeline with over 120 candidates in different stages of development further creates the platform for potential growth of the microbiome therapeutics market.

More Than 120 Drugs Are in the Pipeline in the Global Microbiome Therapeutics Market

At present there are no marketed microbiome therapeutics in the global market; however, the first drug is expected to be launched in 2018. The global market is dominated by over 25 companies with more than 120 drugs in the pipeline at different stages of development. However, over 60% of these drugs are in the discovery or preclinical phase, where there is high uncertainty surrounding the success of these molecules to reach the clinical phase and being launched as a new drug molecule. Majority of the pipeline drugs are being developed for gastrointestinal disorders and contribute approximately 28.7% of the total pipeline products.

Research and development in the microbiome industry is prominently dependent on government funding and research grants. Formation of policies and provision of subsidy by various governments encourages research and development activities across various segments of the research including discovery and clinical research. Government initiatives in funding microbiome research is the preliminary factor driving revenue growth of global microbiome therapeutics market. For instance, the U.S. government had allocated US$ 1.6 Bn for microbiome R&D programs in 2016 & 2017.

Request Report TOC @

Global Microbiome Therapeutics Market: Segmentation and Forecast

The market is segmented based on indication and region. On the basis of indication, the market has been segmented into type 2 diabetes, obesity, C. difficile infection and primary hyperoxyurea. C. difficile infection indication segment is expected to contribute the highest market share of over 34% by 2025 end. More number of product approvals for CDI is attributed to a high share of the C. difficile infection segment in the global market.

Human gut is home to over 100 Tn bacteria, containing thousands of different species. Long-term exposure to antibiotics causes dysbiosis in gut microbial composition, which leads to a variety of gastrointestinal disorders including CDI, ulcerative colitis, IBD, bacterial infection and even antibiotic associated diarrhea. Microbiome therapeutics however, present an excellent option for the treatment of CDI and other gastrointestinal disorders, as they are designed to naturally cure dysbiosis and bring the microbiome system back to normal functioning.

Global Microbiome Therapeutics Market: Regional Forecast

On the basis of region, the market has been segmented into the U.S., Europe, Japan and Rest of the World (RoW). U.S. is estimated to contribute the highest share of over 44% by 2025 end, due to early launch of microbiome therapeutics and high penetration compared to other markets. The market in Japan is expected to witness delayed growth due to the complex regulatory pathways for new biological drugs. The microbiome therapeutics market in the rest of the world is expected to show gradual acceptance of “bug medicine”, Canada being the most lucrative among the rest of the world countries.

Global Microbiome Therapeutics Market: Competitive Landscape

Key players identified in the global microbiome therapeutics market are SERES Therapeutics Inc., Rebiotix Inc., OxThera AB, Immuron Ltd., Microbiome Therapeutics Inc., Ferring B.V., Ritter Pharmaceuticals, LNC Therapeutics, Enterome SA, Synlogic Inc., 4D Pharma Plc. AOBiome LLC, Vedanta Biosciences Inc., ViThera Pharmaceuticals Inc., AvidBiotics, Osel Inc. etc. among others.

Majority of the players in the microbiome therapeutics market are engaged in partnerships and collaborations with established pharmaceutical companies and academic institutes. Small start-up and clinical stage microbiome companies are capitalizing on venture financing to establish microbiome based novel therapeutics in the global market. Despite of decrease in the overall venture capital investments, the microbiome industry has witnessed high VC investments in 2016, and raised approximately to US$ 336 Mn in 2016. Partnerships and research collaborations are another prominent trends identified in global microbiome therapeutics market.

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Improved microbiome sequencing capabilities are likely to boost the global microbiome therapeutics market here

News-ID: 1458990 • Views: 601

More Releases from Persistence Market Research

Exploring the Booming Global Smartwatch Market - Trends, Features, Brands, and Consumer Adoption
Exploring the Booming Global Smartwatch Market - Trends, Features, Brands, and C …
Market Overview: The smartwatch market refers to the industry that produces and sells wearable electronic devices designed to function as a timekeeping device while offering additional features such as health and fitness tracking, notifications, music playback, and more. Smartwatches have gained popularity due to their versatility and integration with smartphones, enhancing user convenience and lifestyle. Market Size and Growth: The global smartwatch market was valued at US$ 32,431.4 Million in 2022. It is
Global Shoulder Replacement Market - Innovations, Trends, Surgical Techniques, and Patient Outcomes
Global Shoulder Replacement Market - Innovations, Trends, Surgical Techniques, a …
Market Overview: The Shoulder Replacement market refers to the medical devices and procedures used for the replacement of damaged or dysfunctional shoulder joints. A surgical intervention aims to alleviate pain, improve mobility, and restore function in patients suffering from conditions such as osteoarthritis, rheumatoid arthritis, and traumatic injuries. Shoulder replacement procedures have gained popularity due to their effectiveness in relieving pain and improving the quality of life for patients. Market Size and
Rare Disease Treatment Market - Breakthrough Therapies, Patient Advocacy, Research Advancements, and Market Dynamics
Rare Disease Treatment Market - Breakthrough Therapies, Patient Advocacy, Resear …
Market Overview: The Rare Disease Treatment market refers to the pharmaceutical and therapeutic interventions aimed at diagnosing, managing, and treating rare diseases. Rare diseases, also known as orphan diseases, are typically characterized by a low prevalence, affecting a small number of individuals. These diseases often have complex and unique medical needs, requiring specialized treatments. Market Size and Growth: The global Rare Disease Treatment market was valued at USD 27 billion in 2017. It
Insights into the Thriving Organic Oats Market - Sustainable Farming, Health Consciousness, and Market Dynamics
Insights into the Thriving Organic Oats Market - Sustainable Farming, Health Con …
Market Overview: The Organic Oats Market refers to the production, distribution, and consumption of oats that are grown following organic farming practices. Organic oats are cultivated without the use of synthetic pesticides, herbicides, genetically modified organisms (GMOs), or chemical fertilizers. They are increasingly popular due to their perceived health benefits and environmental sustainability. Market Size and Growth: The market for organic oats can be expected to expand at a value based CAGR of

All 5 Releases

More Releases for Therapeutics

Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant
Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, N …
The Pruritus Drug Market research report is a significant investigation of changing business sector elements, driving elements, impediments, and limitations that have been considered the most extensive impacts on market development. Adroit investigative devices, for example, Porter’s Five Forces examination, SWOT examination, and Feasibility examination study have likewise been utilized by the report to offer an exhaustive information of the market. It will go about as a key research report
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity. Download the sample report @ It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due
Global mRNA Cancer Vaccines and Therapeutics Market to 2025| Moderna Therapeutic …
Researchmoz added Most up-to-date research on "Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. mRNA Cancer Vaccines and Therapeutics Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the mRNA Cancer Vaccines and Therapeutics industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics,
Global Pruritus Therapeutics Market Report 2019 Companies included Actavis, Trev …
Market Reports Company has recently published 7th edition of Pruritus Therapeutics Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026. For inquiry or free sample pages email us at: The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Pruritus Therapeutics market was valued at USD xx
MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Mode …
WiseGuyReports.Com Publish a New Market Research Report On –“ MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics”. Description:- The mRNA Vaccines & Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, mRNA Vaccines & Therapeutics market size to maintain the average annual growth rate of XXX from